- Home
- LFMD vs ENGN Comparison
LFMD vs ENGN Comparison
Compare LFMD & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- ENGN
- Stock Information
- Founded
- LFMD 1994
- ENGN 1999
- Country
- LFMD United States
- ENGN Canada
- Employees
- LFMD N/A
- ENGN N/A
- Industry
- LFMD Medical/Nursing Services
- ENGN
- Sector
- LFMD Health Care
- ENGN
- Exchange
- LFMD Nasdaq
- ENGN Nasdaq
- Market Cap
- LFMD 306.7M
- ENGN 297.7M
- IPO Year
- LFMD N/A
- ENGN N/A
- Fundamental
- Price
- LFMD $5.68
- ENGN $5.21
- Analyst Decision
- LFMD Strong Buy
- ENGN Buy
- Analyst Count
- LFMD 7
- ENGN 9
- Target Price
- LFMD $11.57
- ENGN $25.22
- AVG Volume (30 Days)
- LFMD 2.0M
- ENGN 36.4K
- Earning Date
- LFMD 03-10-2025
- ENGN 03-10-2025
- Dividend Yield
- LFMD N/A
- ENGN N/A
- EPS Growth
- LFMD N/A
- ENGN N/A
- EPS
- LFMD N/A
- ENGN N/A
- Revenue
- LFMD $212,453,838.00
- ENGN N/A
- Revenue This Year
- LFMD $23.50
- ENGN N/A
- Revenue Next Year
- LFMD $17.20
- ENGN N/A
- P/E Ratio
- LFMD N/A
- ENGN N/A
- Revenue Growth
- LFMD 39.27
- ENGN N/A
- 52 Week Low
- LFMD $3.99
- ENGN $4.42
- 52 Week High
- LFMD $12.88
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- LFMD 52.05
- ENGN 39.24
- Support Level
- LFMD $5.47
- ENGN $4.90
- Resistance Level
- LFMD $5.83
- ENGN $5.46
- Average True Range (ATR)
- LFMD 0.51
- ENGN 0.52
- MACD
- LFMD 0.08
- ENGN 0.02
- Stochastic Oscillator
- LFMD 69.62
- ENGN 31.85
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.